Agenus Doses First Cancer Patient with iNKT Cell Therapy
Go back to Agenus Doses First Cancer Patient with iNKT Cell Therapy| AGENUS (NASDAQ: AGEN) | Delayed: 7.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.53 | 52 Week High | $7.49 | |||
| Open | $7.53 | 52 Week Low | $2.61 | |||
| Day High | $7.53 | P/E | N/A | |||
| Day Low | $7.53 | EPS | $-1.10 | |||
| Volume | 283 | |||||
